Gábor Holló1, Qienyuan Zhou. 1. *Department of Ophthalmology, Semmelweis University, Budapest, Hungary †Optovue Inc., Fremont, CA.
Abstract
PURPOSE: To determine retinal nerve fiber layer thickness (RNFLT) and ganglion cell complex (GCC) progression rates for healthy eyes and undertreatment ocular hypertensive (OHT) and glaucoma eyes with the Avanti RTVue-XR optical coherence tomography. MATERIALS AND METHODS: Seventeen healthy subjects (34 eyes), 17 medically treated OHT patients (34 eyes), and 67 medically treated glaucoma patients (122 eyes) were imaged prospectively at 6-month intervals (median follow-up 5.3 y, 11 visits). RESULTS: A minimal negative correlation between baseline RNFLT and RNFLT progression was found in the glaucoma group (r=-0.1708, P=0.0493). In the other groups no correlation between baseline RNFLT or GCC and RNFLT or GCC progression was found, respectively. The mean±SD of the rate of change was -0.33±0.51, -0.44±0.62, and -0.69±0.93 μm/y for average RNFLT, and -0.53±0.36, -0.54±0.52, and -0.80±0.78 for average GCC, for the normal, OHT, and glaucoma eyes, respectively (P>0.05 for all between-group comparisons). In the normal group the highest progression rate was -1.52 μm/y for average RNFLT and -1.28 μm/y for average GCC. Despite maximal medical treatment, progression in the glaucoma group exceeded the highest progression rate of the normal group in 18 eyes (14.8%) for average RNFLT and 24 eyes (19.7%) for average GCC. CONCLUSIONS: We determined progression rates for untreated healthy and under treatment OHT and glaucoma eyes with the Avanti RTVue-XR optical coherence tomography. We found that an average RNFLT progression rate faster than -1.5 μm/y, and an average GCC progression rate faster than -1.3 μm/y are strongly suggestive for uncontrolled glaucomatous progression. Detection of uncontrolled structural progression with trend analysis may assist the early detection of fast progressors.
PURPOSE: To determine retinal nerve fiber layer thickness (RNFLT) and ganglion cell complex (GCC) progression rates for healthy eyes and undertreatment ocular hypertensive (OHT) and glaucoma eyes with the Avanti RTVue-XR optical coherence tomography. MATERIALS AND METHODS: Seventeen healthy subjects (34 eyes), 17 medically treated OHT patients (34 eyes), and 67 medically treated glaucomapatients (122 eyes) were imaged prospectively at 6-month intervals (median follow-up 5.3 y, 11 visits). RESULTS: A minimal negative correlation between baseline RNFLT and RNFLT progression was found in the glaucoma group (r=-0.1708, P=0.0493). In the other groups no correlation between baseline RNFLT or GCC and RNFLT or GCC progression was found, respectively. The mean±SD of the rate of change was -0.33±0.51, -0.44±0.62, and -0.69±0.93 μm/y for average RNFLT, and -0.53±0.36, -0.54±0.52, and -0.80±0.78 for average GCC, for the normal, OHT, and glaucoma eyes, respectively (P>0.05 for all between-group comparisons). In the normal group the highest progression rate was -1.52 μm/y for average RNFLT and -1.28 μm/y for average GCC. Despite maximal medical treatment, progression in the glaucoma group exceeded the highest progression rate of the normal group in 18 eyes (14.8%) for average RNFLT and 24 eyes (19.7%) for average GCC. CONCLUSIONS: We determined progression rates for untreated healthy and under treatment OHT and glaucoma eyes with the Avanti RTVue-XR optical coherence tomography. We found that an average RNFLT progression rate faster than -1.5 μm/y, and an average GCC progression rate faster than -1.3 μm/y are strongly suggestive for uncontrolled glaucomatous progression. Detection of uncontrolled structural progression with trend analysis may assist the early detection of fast progressors.
Authors: Janelle Tong; Jack Phu; Sieu K Khuu; Nayuta Yoshioka; Agnes Y Choi; Lisa Nivison-Smith; Robert E Marc; Bryan W Jones; Rebecca L Pfeiffer; Michael Kalloniatis; Barbara Zangerl Journal: Am J Ophthalmol Date: 2019-05-10 Impact factor: 5.258
Authors: Anita Lyssek-Boroń; Adam Wylęgała; Katarzyna Polanowska; Katarzyna Krysik; Dariusz Dobrowolski Journal: J Healthc Eng Date: 2017-07-27 Impact factor: 2.682
Authors: Hussein Antar; Edem Tsikata; Kitiya Ratanawongphaibul; Jing Zhang; Eric Shieh; Ramon Lee; Madeline Freeman; Georgia Papadogeorgou; Huseyin Simavli; Christian Que; Alice C Verticchio Vercellin; Ziad Khoueir; Johannes F de Boer; Teresa C Chen Journal: J Glaucoma Date: 2019-11 Impact factor: 2.503